HCPLive

Top Medical News Today

Two Antiplatelets Equal in Head-to-Head Trial
The antiplatelet drugs prasugrel and ticagrelor are both fine for dual antiplatelet therapy following acute myocardial infarctions with ST segment elevations, a Czech study found.
Drug-eluting stents are falling far short of their promises of fewer complications, improved mortality and quality of life, a study found. In the largest study ever done comparing newer drug-eluting stents to bare metal devices, Norwegian researchers found the drug stents did not show a difference in these outcomes.
At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Chris Cannon, MD, Brigham & Women's Hospital, discussed the latest changes with the dyslipidemia guidelines.
Embattled Mylan scored a victory when Teva's patents for Copaxone were invalidated. The decision comes on the eve of a trial in which Teva will fight two other pharmaceutical companies over the right to produce glatiramer acetate treatments for multiple sclerosis.
As one of the leading educational institutions on the island of Grenada, St. George's University plays a unique role not only in helping the students that come to the school to learn but also those who have already called the island home.
It’s no secret that excessive alcohol consumption is dangerous to the liver; that’s exactly why patients with hepatitis C are advised to steer clear of it.
A recent study published in The Journal of Pain looked at the effect of marijuana treatment on neuropathic pain.
Whether medical students learn their craft at the most established institutions or newer schools around the world their ultimate goal is the same, to help the patient in front of them when they enter practice.
As an international university St. Geroge's can take their own route when it comes to preparing their students while still abiding by some of the traditions of other schools in the United States.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$